Article
Ataxia-telangiectasia: Immunodeficiency and survival.
Clinical immunology (Orlando, Fla.) - 1 May 2017
van Os Nienke J H, Jansen Anne F M, van Deuren Marcel, Haraldsson Asgeir, van Driel Nieke T M, Etzioni Amos, van der Flier Michiel, Haaxma Charlotte A, Morio Tomohiro, Rawat Amit, Schoenaker Michiel H D, Soresina Annarosa, Taylor Alexander M R, van de Warrenburg Bart P C, Weemaes Corry M R, Roeleveld Nel, Willemsen Michèl A A P
Abstract excerpt
Ataxia-telangiectasia (AT) is a neurodegenerative disorder characterized by ataxia, telangiectasia, and immunodeficiency. An increased risk of malignancies and respiratory diseases dramatically reduce life expectancy. To better counsel families, develop individual follow-up programs, and select patients for therapeutic trials, more knowledge is needed on factors influencing survival. This retrospective cohort...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.